ZNF609 Inhibitors
Chemical inhibitors of ZNF609 can play a significant role in modulating the signaling pathways that this protein is involved in, particularly concerning muscle cell biology. PD173955, SU6656, and PP2 are all inhibitors of the Src family tyrosine kinases, a group of enzymes that ZNF609 may rely upon for proper signaling in muscle differentiation. The inhibition of these kinases can lead to a decrease in phosphorylation events essential for the role of ZNF609 in muscle cells, thereby functionally inhibiting its activity. For instance, PD173955 can selectively prevent Src kinase activity, potentially disrupting the myogenic signaling pathways where ZNF609 is active. Similarly, SU6656 impairs the signaling required for cytoskeletal organization and muscle cell function, which are processes where ZNF609 is implicated. PP2 further prevents activation of downstream targets involved in cell growth and differentiation, an action that directly impacts ZNF609's role in muscular architecture.
In parallel, other inhibitors such as LDN-193189 and SB431542 target different aspects of muscle cell signaling that can affect ZNF609 function. LDN-193189 is a selective inhibitor of BMP type I receptors, which are involved in myogenic differentiation pathways that ZNF609 is also a part of. By interfering with BMP receptors, LDN-193189 can alter the myogenic signals essential for ZNF609's role. SB431542, on the other hand, inhibits TGF-β type I receptors, which are key in regulating muscle differentiation and function-processes in which ZNF609 participates. Y-27632, a ROCK inhibitor, disrupts the Rho/ROCK pathway, affecting actin cytoskeleton organization and consequently the role of ZNF609 in muscle cells. Gö6976, by inhibiting PKC, can affect multiple cellular signaling pathways, including those governing muscle cell physiology where ZNF609 is involved. ML7 and Blebbistatin target the muscle contraction machinery directly; ML7 by inhibiting MLCK, thus impacting actin-myosin interactions, and Blebbistatin by inhibiting myosin II ATPase activity, both crucial for the muscle function associated with ZNF609. Lastly, Concanavalin A and Genistein can alter cell surface receptor-mediated signaling and a wide range of kinase activities, respectively, thereby modulating the various signaling pathways necessary for ZNF609's functional activity in cell differentiation and development.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PD 173955 | 260415-63-2 | sc-507378 | 10 mg | $320.00 | ||
PD173955 is a selective inhibitor of Src family tyrosine kinases. ZNF609 has been implicated in the regulation of muscle differentiation, and Src kinases can play a role in myogenic signaling pathways. Inhibition of Src by PD173955 can reduce phosphorylation events that are necessary for muscle cell differentiation and maintenance, thus functionally inhibiting ZNF609's role in myogenesis. | ||||||
SU6656 | 330161-87-0 | sc-203286 sc-203286A | 1 mg 5 mg | $57.00 $133.00 | 27 | |
SU6656 is another inhibitor of the Src family tyrosine kinases. By inhibiting Src kinase activity, SU6656 can impair the signaling required for cytoskeletal reorganization and muscle cell function, thereby functionally inhibiting the role of ZNF609 in muscle cell biology. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is an inhibitor of Src family kinases and can prevent the activation of downstream targets involved in cell growth and differentiation. Through this inhibition, PP2 can disrupt pathways essential for the function of ZNF609 in the development and maintenance of muscular architecture. | ||||||
PP 3 | 5334-30-5 | sc-203213 sc-203213A sc-203213B | 1 mg 5 mg 10 mg | $82.00 $130.00 $180.00 | 1 | |
PP3 is often used as a negative control for PP2 as it is an inactive analogue. However, in high concentrations, PP3 can exhibit non-specific inhibitory effects on cellular signaling pathways that might involve ZNF609 activity, albeit less selectively than its active counterpart PP2. | ||||||
4-(6-(4-(Piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline | 1062368-24-4 | sc-476297 | 5 mg | $240.00 | ||
LDN-193189 is a selective inhibitor of BMP (Bone Morphogenetic Protein) type I receptors ALK2 and ALK3. ZNF609 is known to be involved in myogenic differentiation, and BMP signaling is a critical pathway in this process. Inhibition of BMP receptors by LDN-193189 can compromise the myogenic signals required for ZNF609's role in muscle cell differentiation. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
SB431542 is an inhibitor of the TGF-β type I receptor ALK5, as well as ALK4 and ALK7. Since TGF-β signaling regulates muscle differentiation and function, and ZNF609 is involved in myogenesis, inhibition of this pathway by SB431542 can functionally inhibit the role of ZNF609 in these cells. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is an inhibitor of Rho-associated protein kinase (ROCK). The Rho/ROCK pathway is implicated in actin cytoskeleton organization, which is crucial for muscle cell function and differentiation. Inhibition of ROCK by Y-27632 can therefore impair the cytoskeletal dynamics and processes that ZNF609 is involved in. | ||||||
Gö 6976 | 136194-77-9 | sc-221684 | 500 µg | $227.00 | 8 | |
Gö6976 is a classic protein kinase C (PKC) inhibitor. PKC plays a role in a wide variety of cellular signaling pathways, including those that govern muscle cell physiology. By inhibiting PKC, Gö6976 can disrupt the signal transduction pathways that ZNF609 requires for its functional role in muscle biology. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $91.00 $267.00 | 13 | |
ML7 is an inhibitor of myosin light chain kinase (MLCK). Since MLCK is involved in muscle contraction and cell motility processes, its inhibition by ML7 can disrupt the actin-myosin interaction critical for muscle function, thereby impacting ZNF609's role in muscle cell biology. | ||||||
(S)-(−)-Blebbistatin | 856925-71-8 | sc-204253 sc-204253A sc-204253B sc-204253C | 1 mg 5 mg 10 mg 25 mg | $72.00 $265.00 $495.00 $968.00 | ||
Blebbistatin is an inhibitor of myosin II ATPase activity. Myosin II is essential for muscle contraction and cell motility. By inhibiting myosin II, Blebbistatin can impede the muscle functions that ZNF609 is associated with, thus functionally inhibiting its role. | ||||||